Determinants of survival in patients on extracorporeal membrane oxygenation therapy due to severe covid-19.
Russlan NatanovElena R KunkelOlaf WiesnerAxel HaverichBettina WiegmannStefan RümkeChristian KühnPublished in: Perfusion (2022)
Pre-existing cardiovascular disease, higher age, history of nicotine abuse, and development of renal failure are associated with poor outcome. Early start of vv-ECMO therapy may lead to better survival in sCOVID-19 patients, although complications during ECMO therapy are associated with a worse prognosis.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- end stage renal disease
- cardiovascular disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- sars cov
- type diabetes
- metabolic syndrome
- intensive care unit
- coronary artery disease
- patient reported outcomes
- early onset
- free survival
- intimate partner violence